These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5042953)

  • 1. Central nervous system response of horses to Venezuelan equine encephalomyelitis vaccine (TC-83).
    Monlux WS; Luedke AJ; Bowne J
    J Am Vet Med Assoc; 1972 Aug; 161(3):265-9. PubMed ID: 5042953
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
    Monlux WS; Luedke AJ; Mercado S; Rosales JC; Rios R
    J Am Vet Med Assoc; 1972 Oct; 161(7):832-3. PubMed ID: 4669261
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
    Monlux WS; Luedke AJ; Mercado S; Rosales JC
    J Am Vet Med Assoc; 1972 Oct; 161(7):832-3. PubMed ID: 5074265
    [No Abstract]   [Full Text] [Related]  

  • 4. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
    Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
    Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
    Barber TL; Walton TE; Lewis KJ
    Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis.
    Jochim MM; Barber TL
    J Am Vet Med Assoc; 1974 Oct; 165(7):621-5. PubMed ID: 4422323
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmissibility of an attenuated Venezuelan equine encephalomyelitis vaccine virus.
    Taylor WM; Buff E
    J Am Vet Med Assoc; 1972 Jul; 161(2):159-63. PubMed ID: 4402529
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP
    Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae.
    Spertzel RO; Kahn DE
    J Am Vet Med Assoc; 1971 Sep; 159(6):731-8. PubMed ID: 5158756
    [No Abstract]   [Full Text] [Related]  

  • 10. Duration of immunity of horses vaccinated with strain TC-83 Venezuelan equine encephalomyelitis virus vaccine.
    Walton TE; Luedke AJ; Jochim MM; Crenshaw GL; Ferguson JA
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):196-202. PubMed ID: 4534711
    [No Abstract]   [Full Text] [Related]  

  • 11. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study.
    Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL
    Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial measurements of serum protein, glycoprotein, and lipoprotein fractions in normal and Venezuelan equine encephalomyelitis-vaccinated ponies and burros.
    Rollins JB; Shultz TD; Fiser RH
    Am J Vet Res; 1972 Feb; 33(2):323-7. PubMed ID: 5059867
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on immunity to alphaviruses in foals.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1979 Jan; 40(1):5-10. PubMed ID: 453684
    [No Abstract]   [Full Text] [Related]  

  • 16. Venezuelan equine encephalomyelitis: past, present, and future.
    McConnell S
    J Am Vet Med Assoc; 1972 Dec; 161(11):1579-83. PubMed ID: 4565076
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence of neutralizing antibody in Equidae vaccinated with Venezuelan equine encephalomyelitis vaccine strain TC-83.
    Walton TE; Johnson KM
    J Am Vet Med Assoc; 1972 Oct; 161(8):916-8. PubMed ID: 5074268
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses.
    Pedersen CE
    J Clin Microbiol; 1976 Feb; 3(2):113-8. PubMed ID: 942635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.